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Single molecule real time 
sequencing in ADTKD-MUC1 allows 
complete assembly of the VNTR 
and exact positioning of causative 
mutations
Andrea Wenzel1, Janine Altmueller1,2, Arif B. Ekici  3, Bernt Popp 3, Kurt Stueber4,  
Holger Thiele2, Alois Pannes10, Simon Staubach1,7, Eduardo Salido5, Peter Nuernberg2, 
Richard Reinhardt4, André Reis  3, Patrick Rump  6, Franz-Georg Hanisch7,  
Matthias T. F. Wolf8, Michael Wiesener9, Bruno Huettel4 & Bodo B. Beck1
Recently, the Mucin-1 (MUC1) gene has been identified as a causal gene of autosomal dominant 
tubulointerstitial kidney disease (ADTKD). Most causative mutations are buried within a GC-rich 60 
basepair variable number of tandem repeat (VNTR), which escapes identification by massive parallel 
sequencing methods due to the complexity of the VNTR. We established long read single molecule real 
time sequencing (SMRT) targeted to the MUC1-VNTR as an alternative strategy to the snapshot assay. 
Our approach allows complete VNTR assembly, thereby enabling the detection of all variants residing 
within the VNTR and simultaneous determination of VNTR length. We present high resolution data on 
the VNTR architecture for a cohort of snapshot positive (n = 9) and negative (n = 7) ADTKD families. 
By SMRT sequencing we could confirm the diagnosis in all previously tested cases, reconstruct both 
VNTR alleles and determine the exact position of the causative variant in eight of nine families. This 
study demonstrates that precise positioning of the causative mutation(s) and identification of other 
coding and noncoding sequence variants in ADTKD-MUC1 is feasible. SMRT sequencing could provide 
a powerful tool to uncover potential factors encoded within the VNTR that associate with intra- and 
interfamilial phenotype variability of MUC1 related kidney disease.
Autosomal dominant tubulointerstitial kidney disease (ADTKD; formerly known as medullary cystic kidney 
disease (MCKD)) constitutes a prototypic group of usually slower progressive nephropathies. ADTKD can man-
ifest in childhood, but typically comes to medical attention with chronic kidney disease from early adulthood 
onwards1–4.
With the recently identified ADTKD-MUC1 subtype (OMIM #174000; originally referred to as MCKD type 1), 
four genes (UMOD (OMIM #603860, #162000 and #609886; ADTKD-UMOD; MCKD type 2), REN (OMIM 
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#613092; ADTKD-REN), and HNF1B (OMIM #137920; ADTKD-HNF1B)) have so far been repeatedly assigned 
to the ADTKD-spectrum1,5–8. Shared clinical features in ADTKD and phenotype overlap with other renal kidney 
diseases (RKDs) frequently make a definite clinical or histopathological diagnosis difficult4,8,9. Sanger sequencing 
or NGS based analyses of the first three identified genes is a widely available standard, while analysis of the MUC1 
gene still poses a substantial diagnostic problem. ADTKD-MUC1 constitutes the first kidney disorder where 
mutations reside within a coding variable number of tandem repeat (VNTR contained in exon 2). The inaccessi-
bility of many genomic repeats to direct short-read based sequencing approaches explains why the association of 
the MUC1 gene to ADTKD has been obscured for long5.
In contrast to simple tandem repeats commonly seen in (coding and noncoding) repeat expansion dis-
eases (e.g. Huntington Disease or Fragile X Syndrome etc.) the actual size of the coding 60 basepair VNTR in 
ADTKD-MUC1 seems irrelevant to the pathomechanism of ADTKD (Fig. 1)5,10,11. As the VNTR size of each 
parental MUC1 allele is highly polymorphic (usually between 20 to 125 units per allele) with no expansion or 
retraction of units, commonly used methods to detect repeat size alterations are per se useless here12.
The prototypic causative variant in MUC1 associated ADTKD, the insertion of a eighth cytosine base (insC) 
in a seven cytosine stretch within one unit of the VNTR composed of almost identical 60-mer units (according 
Figure 1. (a) Localization and consequences of the cytosine insertion in the VNTR domain of the MUC1 gene. 
Exons 1–7 of the MUC1 gene are shown on cDNA level (UniProt ID P15941). Domains of the corresponding 
full-length protein are displayed (TM, transmembrane domain; SEA, sea-urchin sperm protein, enterokinase 
and agrin-domain). The cytosine insertion into the 7C-homopolymer in a single repeat unit of the variable 
number of tandem repeats (VNTR) domain is exemplarily introduced into the next-to-last repeat unit 
(indicated by arrows). In the lower part, coding genomic VNTR sequence and the corresponding amino acid 
sequence are shown for WT and the insC mutant. The insC causes a frameshift introducing a premature stop 
codon shortly beyond the VNTR domain and thereby, creating a ‘neoprotein‘ lacking the SEA, TM and the 
cytoplasmic domains (b) MUC1-VNTR assembly of the risk allele in family F1. The complete VNTR sequence 
is shown for affected individuals III-10, IV-16, IV-27, and IV-28. This allele was identified in all affected 
individuals but it was not identified in unaffected individuals. The insC was detected in the second consensus 
repeat (highlighted in red). Capital letter code of the 60 mer VNTR-units according to Kirby et al. are displayed 
next to each repeat sequence. Nucleotide sequence differences within the repeat units are highlighted in dark 
grey. Uniform pseudo-repeats (nonvariable) units at beginning and at the end of the VNTR are underlined.
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to HGVS nomenclature recommendations a duplication, but for the sake of clarity we stay with term insertion 
used in most publications), has been repeatedly found worldwide (also arbitrarily referred to as c.428dupC)4,5. 
Based on the VNTR assembly from three families, the exact location of the insC with regard to the unit number 
seemed to be variable, although always occurring within the 7C-homopolymer at relative base positions 53–59 of 
the 60-mer unit (Fig. 1)5. Due to the nature of the VNTR, insC within different located 60-mer unit numbers as 
well as other small insertions or deletions located at different positions, would result in a frameshift leading to a 
similar, presumably toxic MUC1-neoprotein that is retained within the cell (Fig. 1)5.
The signal transducing transmembrane MUC1 protein is abundantly expressed in most epithelia and 
over-expressed in epitheloid malignancies. MUC1 is also expressed in renal development and later found at the 
apical surfaces of normal kidney epithelia that form luminal surfaces13–16. The role of MUC1 in the kidney is not 
very clear apart from the N terminal ectodomain of the glycoprotein being released into the urine. At urothelial 
surfaces MUC1 and uromodulin form protective polymer layers. Recently it was shown that MUC1 regulates the 
renal calcium channel TRPV5 and potentially is protective against calcium nephrolithiasis by increasing urinary 
calcium reabsorption17.
Since the high GC content in combination with the genomic architecture of the VNTR largely prevents direct 
sequencing, a probe extension (snapshot) assay refined by mass spectrometry validation has been developed as a 
first diagnostic test. The test needs to accomplish the detection of a single 60-mer unit carrying the insC against a 
high background of normal units (expected frequency between 0.8% (1/125 units) to 5% (1/20 units) depending 
on individual VNTR allele sizes)4,5,18. The evident limitations of the assay, the loss of almost all structural and 
positional information, led us to hypothesize on the existence of other causative alterations located within the 
VNTR that cannot be interrogated by the current assay.
To generate complete VNTR assemblies we thus adapted targeted single molecule real time (SMRT) sequenc-
ing on the PacBio RS II platform. We argued that this method could improve the testing in general and especially 
of sporadic cases, a group that has been largely omitted from current studies4,5,19,20. We show precise VNTR struc-
tural assembly and location of the causative insC, a prerequisite for identification of additional causative variants 
within the VNTR and detailed characterisation of genotype-phenotype correlations in ADTKD-MUC1.
Material and Methods
Probands. All investigations were conducted in accordance with the principles of the Declaration of Helsinki 
and after obtaining written informed consent. The study was approved by the local institutional review boards of 
the Universities of Cologne (IRB approval Nr 237/2013). Out of our (non-syndromal) ADTKD cohort previously 
tested negative for the ADTKD-genes UMOD, REN and HNF1B (including MLPA analysis for HNF1B, SALSA 
MLPA P241; MRC-Holland) we selected DNA samples from 9 families with positive snapshot findings as well as 
six families and one sporadic case with negative snapshot results who were still suspected to have ADTKD-MUC1 
based on their clinical course and kidney biopsy findings for SMRT sequencing. Clinical and biochemical data 
were collected retrospectively from medical charts.
MUC1 VNTR PCR. Proband DNA was extracted from blood samples by NaCl precipitation and 30ng 
genomic DNA were used as templates21. The PCR protocol was adapted from a previous study with slightly 
modified cycling conditions and PCR composition22. Custom-designed 16 bp barcodes were added to the PCR 
primers for multiplexing different individuals following the guidelines for using PacBio Barcodes for SMRT 
Sequencing (Pacific Biosciences). Briefly, 25 µl reactions contained 30 ng of genomic DNA, 0.25 µM of PS2 
(5′-XXXXXXXXXXXXXXXGGAGAAAAGGAGACTTCGGCTAC CCAG-3′; X stands for each nucleotide) and 
PS3 (5′-XXXXXXXXXXXX XXXXGCCGTTGTGCACCAGAGTAGAAGCTGA-3′) primers, 5% DMSO, 0.4 µM 
dNTP´s, 1 × reaction buffer with 1.5 mM MgCl2, 250 µM MgCl2, and 0.9 U DyNAzyme EXT DNA polymerase 
(Finnzymes, GRI Research, Braintree, UK). Thermocycling on C1000 touch instruments (Bio-Rad) included ini-
tial denaturation (1 min 30 s at 96°), 24 cycles (40 s at 96°, 30 s at 65° and 6 min at 68°) and final extension (10 min 
at 68°). The reaction was conducted three times for each sample, which were subsequently pooled. Amplification 
of VNTR (25 µl of each pooled sample) was verified by agarose gel electrophoresis (0.7%). The GeneRuler DNA 
Ladder (1 kb, 0.5 µg/µl, Fermentas) was used as a size marker. The remaining PCR products (50 µl) were sorted 
by allele length: (<4000 bp (≤66 variable repeat units) or >4000 bp (≥66 variable repeat units)), diluted 1:2 
with H2O and purified using AMPure beads (Agencourt) according to the manufacturer´s instructions. AMPure 
bead:DNA ratio was adapted to the length of the allele of interest. Molar concentration was verified using the 
Qubit 3.0 Fluorometric Quantitation system (ThermoFischer).
Library preparation and SMRT sequencing. Target amplicons of equal size were pooled equimo-
lar and a SMRT bell library was prepared as recommended by Pacific Biosciences (10 kb Template Preparation 
and Sequencing with Low-Input DNA) without an initial fragmentation. Raw sequence data is available upon 
request. Libraries were quantified by fluorometry and quality was assessed by capillary electrophoresis (Agilent 
DNA 12000 reagents and chips, Agilent). SMRT bell templates were bound to polymerases using the DNA/pol-
ymerase binding kit P6 and v2 primers. Polymerase-template complexes were bound to magnetic beads with the 
Magbead Binding Kit and sequencing was done on the PacBio RS II sequencer with C4 sequencing reagents with 
a movie length of 180 or 360 min. Cluster analysis to extract haplotypes of individuals was done with the in house 
algorithm (Wenzel and Pannes unpublished). Amplicons were split according to the 16mer barcodes of PacBio. 
Additionally amplicons were split with a Perl script.
Assembly of the MUC1 VNTR using an in-house algorithm. Assembly of both paternal VNTR alleles 
was performed with the help of an in-house developed algorithm using a database-software (Microsoft ACCESS). 
The barcode-separated reads were converted into text files using Notepad++ editor and loaded into the database. 
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Each single read was recognized by “ > m” (fasta format) and at the end by barcodes, respectively. The second step 
included the identification of start and end of each single 60-mer repeat unit by known and universal sequences 
of fixed repeat units 1 and 9. Part three included the determination of the repeat type based on sequences of 
actual known repeat variants described in Kirby et al. Certain repeat types are recognized based on selected base 
pair sequences within one repeat unit. The 60 basepair sequences of all known repeat types were subdivided into 
9 “identification sequences”, respectively, each with a length of 4 bases in a row. This procedure overcomes the 
sequence variation based on reading failures made by the polymerase. Reconstruction of the repeat type assembly 
can be transferred into Microsoft EXCEL including two sheets: 1. Identified repeat variants corresponding to the 
capital letter code provided by Kirby et al.5 are shown in the first sheet for every single read allowing complete 
VNTR assembly. If one repeat unit type cannot be identified this position remains blank providing the possi-
bility to identify so far unknown repeat variants. 2. The second sheet contains the sequence of each single read 
including the identified repeat variant, respectively, allowing the verification of identified and not identified single 
repeat units by manual inspection. For each individual two different alleles were identified.
Data Availability. The publicly accessible database listed below:
National Center for Biotechnology Information (NCBI; http://ncbi.nlm.nih.gov/),
UCSC Genome Bioinformatics (http://genome.ucsc.edu/),
1000 Genomes (http://1000genomes.org/) and
Broad Institute (http://exac.broadinstitute.org).
The datasets generated during and/or analysed during the current study using the in-house algorithm are 
available from the corresponding author on reasonable request.
Results
Prerequisites for MUC1-VNTR long-read sequencing. Using a modified PCR protocol published by 
Fowler et al. allowed stable generation of PCR amplicons across a wide range of MUC1 VNTR allele sizes (from 
25 to 74 60-mer units corresponding to ca. 1.5 to 4.5 kb amplicons) that could be visualized by agarose gel elec-
trophoresis (Fig. 2)22.
The fidelity of the PCR was validated by allele length determination using Southern blot analysis (data not 
shown).
We observed preferential amplification of shorter VNTR alleles (<4 kb), a phenomenom that is known as 
short allele dominance23,24. PCR amplification had to be repeated for 8 out of 43 individuals with at least one long 
allele, for PCR failure.
Targeted SMRT sequencing of the MUC1-VNTR. Direct sequencing of the long-range MUC1-VNTR 
on the PacBio RS II platform was performed in 43 individuals (16 unaffected, 32 affacted) in 6 independent runs 
and resulted in an average sequencing depth of 160 complete reads (minimum 4, maximum 600 reads). Libraries 
were prepared by pooling 5 to 18 long-range (LR) PCR products depending on VNTR size that were subsequently 
analyzed on single SMRT cells.
Short allele dominance was observed in the first run. Shorter VNTR alleles (<4 kb) were overrepresented 
(range 32 to 600 complete reads) compared to longer alleles (range 4 to 229 complete reads). To minimize 
this effect PCR products were pooled for library preparation according to their length in all further runs into 
two libraries containing amplicons <4 and >4kb, respectively (for detailed information please see Material & 
Methods). This measure improved read depth for the longer alleles (range 36 to 440 complete reads).
Sequencing had to be repeated for 8 individuals for low complete VNTR coverage, which was mostly associ-
ated with allele size >4kb.
Figure 2. PCR amplification of the MUC1-VNTR. Depiction of amplicons spanning the MUC1-VNTR of 
families F1 to F7 separated by agarose gel electrophoresis (0.7% gel). Product sizes range between 2000 and 
5000 bp. C, water control (see Table 1 and Fig. 4a).
www.nature.com/scientificreports/



















F1 CHE 4/4 3/3 ≥20
III-10 affected 1 35 2 2641
male ESRD (60y) 2 35 — 2640
IV-16 affected 1 35 2 2641 bp
female CKD2 (39y) 2 41 — 3000 bp
IV-27 affected 1 35 2 2641
female CKD3 (35y) 2 43 — 3120
IV-28 affected 1 35 2 2641
male CKD2–3 (46y) 2 36 — 2700
IV-17 unaffected 1 35 — 2640
male (37y) 2 41 — 3000
IV-21 unaffected 1 35 — 2640
female (52y) 2 73 — 4920
V-12 unaffected 1 35 — 2640
male (18y) 2 43 — 3120
F2 GER 2/2 1/1 ≥7
II-11 affected 1 71 14 4801
male ESRD (32y) 2 35 — 2640
III-7 affected 1 71 14 4801
female CKD1–2 (29y) 2 73 — 4920
II-12 unaffected 1 35 — 2640
female (63y) 2 73 — 4920
F3* GER 3/3 1/1 ≥40
V-12 affected 1 73 ambiguous 4921
male ESRD (41y) 2 35 — 2640 bp
V-23 affected 1 73 ambiguous position 4921 bp
female ESRD (43y) 2 71 — 4800
V-18 affected 1 73 ambiguous position 4921
male ND 2 25 — 2040
VI-6 unaffected 1 41 — 3000
male (44y) 2 34 — 2580
F4* GER 1/1 1/1 ≥9
III-8 affected 1 70 8 4741
ESRD (41y) 2 35 — 2640
IV-7 unaffected 1 42 — 3060
(39y) 2 35 — 2640
F5* GER 2/2 0/0 4
III-1 affected 1 71 39 4801
male ESRD (43y) 2 67 — 4560
III-2 affected 1 71 39 4801
female CKD3 (40y) 2 67 — 4560
F6 GER 2/2 0/0
III-1 affected 1 66 29 4501
male ESRD (ND) 2 61 — 4200
IV-1 affected 1 66 29 4501
male CKD3 (33y) 2 66 — 4500
F7 NLD 1/1 0/0 ≥8
III-1 affected 1 74 39 4981
female ESRD (49y) 2 42 — 3060
F8 TUR 3/3 0/0 ≥4
II-7 affected 1 69 14 4681
female ESRD (60y) 2 68 — 4560
III-5 affected 1 69 14 4681
female ESRD (39y) 2 34 — 2580
Continued
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MUC1 VNTR SMRT sequencing in ADTKD families previously tested positive. In all 9 families 
SMRT sequencing reconfirmed the insC previously detected by the probe extension assay with the exception of F7 
in whom the insC was first identified by SMRT sequencing and later reconfirmed by the snapshot method (data 
not shown). In three families (F3*-F5*) the insC has been previously reported by Ekici et al., while the remaining 
six families (F1-F2, F6-F9) represent new families (Fig. 3)4.
Interfamilial variability of insC position within the X-unit in the VNTR. SMRT sequencing con-
sistently enabled us to generate sequence reads that allowed for complete assembly of both the wildtype and the 
ADTKD risk allele carrying the insC.
The precise location of the 60-mer unit location harbouring the insC within the MUC1-VNTR could be solved 
in eight of the nine positive families studied. In family F3 the insC was detected in three affected family members, 
but for unclear reasons we were not able to locate the precise 60-mer unit here.
Position of the insC ranged (counting only the variable units; see Fig. 4a, Table 1) from the second up to the 
39th unit and always occurred on the background of the X unit which is the most abundant 60-mer unit found 
within the VNTR (51.4–62.0%). The exact position of the causative variants was consistent in all affected individ-
uals within families. Two families (F5 and F7) carried the insC in the 39th variable unit, but their VNTR assembly 
and allele size was different (Table 1, Figs 3 and 4a). Of note the Swiss family F1 demonstrated exactly the same 
risk allele assembly and position of the prototypic mutation within the second X unit as one family (family 4) 
previously reported by Kirby et al.5 Identical assembly could indicate that these two families are related.
SMRT sequencing in unclear non UMOD/HNF1B/REN ADTKD families. To further investigate our 
hypothesis that the VNTR might be a mutational hotspot prone to other mutations (e.g. small deletions etc.) 
within or outside of the 7C homopolymer a small cohort of three large families (F12, F13, and F16), three smaller 
families (F10, F14 and F15) and one sporadic case (F11), all compatible with a diagnosis of ADTKD-MUC1, were 
analysed (Table 2, Fig. 4b).
No other small insertion or deletion resulting in a frameshift consequence and no causative structural var-
iant could be detected by complete VNTR assembly, although family F12 demonstrated linkage to a 12.9 Mb 
interval encompassing the MUC1-locus on chromosome 1q21 with a maximum parametric LOD score of 1.8 
under assumption of autosomal dominant inheritance (data not shown; only affected individuals analyzed)25. No 
linkage data were available of the latter two larger families F13 and F16. Large deletions and loss of heterozygosity 
(LOH) could be excluded in this cohort as we were always able to reconstruct two parental VNTR alleles.
MUC1 mutations outside the VNTR were excluded by Sanger sequencing in all families (plus whole exome 
sequencing in F12).
Identification of novel repeat variants. We found altogether nine novel repeat variants and annotated them 
in continuation of the one letter code introduced by Kirby et al. (Fig. 5) since there is no suitable HGVS nomencla-
ture for complex tandem repeat (TR). Three of these repeat variants include the following non-synonymous SNPs 
on relative repeat position 7G > A (p.G3S), position 22C > A (p.P8T), position 40C > A (p.P14T) termed Q, R, 
and N. In addition three novel repeat variants with synonymous SNPs were found, which were termed L (rel. posi-
tion 18G > A, p.P6=), O (rel. position 42G > A, p.P6=), and P (36G > A, p.P6=). The remaining repeat variants 
5C, M and S consist of previously described SNPs in a novel combination. Variant 5C is a fusion of previously 
described variants 5 (fixed variant) and C (non-synonymous SNPs at rel. positions 8G > A (p.G3D) and 59C > A 
(p.P20Q)). The repeat variant M contains one synonymous SNP at rel. position 21C > A (p.P7=) and variant S three 
non-synonymous known SNP´s at relative positions 27C > G (p.D9E), 29C > G (p.T10S), and 58C > G (p.P20A).
Discussion
Sequencing with the PacBio RS II system based on single molecule real time (SMRT) technology offers the ben-
efit of extraordinarily long sequencing reads with high accuracy. We adapted SMRT for targeted sequencing 



















III-6 affected 1 69 14 4681
female CKD3 (37y) 2 34 — 2580
? unaffected 1 35 2640
male (30y) 2 68 4620
? unaffected 1 34 2580
male (38y) 2 72 4860
F9 GER 1/1 0/0 3
II-2 affected 1 34 24 2581
female ESRD (44y) 2 60 — 4140
Table 1. Summary of 9 ADTKD-MUC1 families with complete assembly of both MUC1-VNTR alleles tested 
positive by SMRT sequencing. *Indicates that families F*3 to F*6 have been previously reported4. F, family; 
CKD, chronic kidney disease stage and age at CKD stage in years; ESRD, endstage renal disease and age at 
ESRD in years; KTx, kidney transplantation; ND, no data available; CHE, Switzerland; GER, Germany; NLD, 
Netherlands; TUR, Turkey; neg, negative; pos, positive; y, years.
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comparatively low capacity of the system made the generation of PCR amplicons spanning the VNTR indispen-
sable. SMRT sequencing has been previously performed for complex genomic regions, including another mucin, 
encoded by the MUC5AC gene, mainly secreted in the respiratory tract26.
The discovery of the genetic basis of this long sought ADTKD type cannot be overemphasized as it has opened 
the field of tandem repeats to the spectrum of hereditary kidney disease. The paper by Kirby et al. also points 
out to the pitfall of missing hereditary disease contained in those repetitive sequences with the current strategies 
employed in gene identification studies5.
Tandem repeats (TR) are a major class of repetitive DNA which makes up for a significant amount of the 
humane genome. TR the size of 9 to 80 bp that are repeated a few to more than a hundred times are also called 
VNTRs as they can be highly polymorphic within a population. From a molecular point of view tandem repeat 
polymorphisms (TRPs) provide a dynamic source of genomic variability as their mutation rate is higher and the 
extent of polymorphism (multiallelic) is more diverse than that contained in single nucleotide polymorphisms 
(SNPs). Expansions in short/simple TR´s are known to cause many monogenic disorders, which mainly result in 
neurodegenerative disease.
The technical dilemma caused by the difficult nature of the VNTR’s genomic sequence (tertiary structure 
resulting from the repetitive sequence, GC content, and repeat length) is well illustrated by the surprisingly few 
publications on ADTKD-MUC1 after the initial description. These inherent problems have created a diagnostic 
Figure 3. Families with ADTKD. Pedigrees of the nine InsC positive families. Black symbols indicate affected 
individuals, white symbols indicate unaffected status, and slashed symbols indicate deceased individuals. 
DNA for SMRT sequencing analysis was available from all individuals marked with arrows. Generations are 
numbered in roman numerals.
www.nature.com/scientificreports/
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bottleneck for MUC1 testing worldwide with only a few laboratories performing the probe extension assay and 
only one laboratory being able to validate the snapshot assay by mass spectrometry4,5,20,27.
SMRT sequencing allowed complete assembly of both the wildtype and the ADTKD risk allele and precise 
positioning of the insC in all families (except family F3). In contrast even mutations occurring at the 5′ and 3′ 
borders of the VNTR are usually not accessible to Sanger sequencing or to short read based NGS technologies.
The reason why several affected family members from F3 repeatedly showed ambiguous position of the insC 
on various X units remains unexplained, but could not be related to a low number of complete VNTR reads. 
Interestingly, the prototypic mutation insC was exclusively found on the background of the X unit in our cohort. 
In contrast the only other publication providing data on VNTR assembly identified the insC on the variable 
X- and B- unit and on the”fixed” 5-unit5. Our observation could be an accidental finding as the number of ana-
lysed families in our study was still small and the X unit constitutes the most abundant unit within the VNTR. A 
Figure 4. (a) Complete assembly of the risk and non-risk MUC1-VNTR alleles from positive tested families 
F1–9. For all families (F1–9), the structure of the risk MUC1-VNTR allele and the exact position of the single 
mutant repeat unit (with exception of family 3) and their sequence context were determined, respectively. 
Representative assembly of the VNTR as a series of 60mer units covering hg19 chr1 positions 155,160,963 to 
155,162,030 (inclusive), and oriented relative to the MUC1 coding strand (Human GRCH37/hg19; negative 
strand). Repeat units shown in red contain the insertion of an additional C into the seven C-stretch sequence 
appearing at relative positions 53–59 of a single repeat unit. Non-risk alleles are shown for all individuals. 
Uniform pseudo-repeat units 1–5 and 6–9 encompassing the variable repeat region are underlined. The 
assembly of the hypervariable VNTR is not arbitrary, but rather follows uniform patterns where certain unit 
stretches were conserved in all individuals between families regardless of the VNTR allele size. Uniform repeat 
type stretches are highlighted with different colours. (b) Complete assembly of both MUC1-VNTR alleles 
from negative tested families F10–16. For all families (F10–16) the structure of both MUC1 VNTR alleles were 
determined. Exemplary depiction of VNTR assembly as a series of 60mer units covering hg19 chr1 positions 
155,160,963 to 155,162,030 (inclusive), and oriented relative to the MUC1 coding strand (hg 19 negative 
strand). Uniform pseudo-repeat units 1–5 and 6–9 encompassing the variable repeat region are underlined. 
Uniform repeat type stretches are highlighted with different colours. In the asymptomatic individual III-7 of 
F12 the fixed unit 6′ is lacking the last 18 bases (marked with an *) and unit 7 is completely missing.
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binomial test calculates a one-tailed P-value of 0.016 for the chance of exactly 8 mutational hits in the X unit in 8 
families, which does not support the hypothesis of a chance finding.
By pinpointing the precise repeat unit carrying the prototypic insC we could confirm the allelic heterogeneity 
of MUC1 associated kidney disease. The mutational spectrum is further expanded by a recent study that identi-



















F10 GER 0/0 1/1 ≥4
affected 1 34 — 2580
male ESRD (55y) 2 73 — 4920
F11 GER 0/0 1/1 1
I-1 affected 1 68 — 4620
female ESRD (xxy) 2 74 — 4980
F12 GER 0/0 3/3 ≥8
II-6 affected 1 35 — 2640
female 2 37 — 2760
II-8
affected 1 35 — 2640
female CKD 3 (60y) 2 70 — 4740
III-4 affected 1 35 — 2640
male 2 21 — 1800
III-5 affected 1 35 — 2640
male 2 21 — 1800
III-6
affected 1 35 — 2640
female ESRD (27y) 2 61 — 4200
III-7 affected
1 35 — 2640
male CKD 3 (26y) 2 36 — 2700
II-7 unaffected 1 36 — 2700
male 2 61 — 4200
III-8 unaffected 1 61 — 4200
female (24y) 2 70 — 4740
F13 NDL 0/0 1/1 ≥6
III-1 affected 1 34 — 2580
female ESRD (41y) 2 40
— 2940
F14 GER 0/0 1/1 ≥2
II-1 affected
1 68 — 4620
female ERSD (43y) 2 33 — 2520
F15 CHE 0/0 1/1 2
III-1 affected 1 35 — 2640
male CKD 3 (44y) 2 73 — 4920
II-2 affected 1 35 — 2640
female 2 57 — 3960
—
II-1 unaffected 1 66 — 4500
? 2 73 — 4920
F16 NDL 0/0 1/1 ≥18
III-9 affected 1 33 — 2520
male CKD2–3 (66y) 2 65 — 4250
Table 2. Summary of the 7 suspected ADTKD-MUC1 families (previously tested negative for UMOD, REN, 
HNF1B and MUC1 by the snapshot method) with unremarkable SMRT sequencing results, despite complete 
assembly of both VNTR alleles. F, family; CKD, chronic kidney disease stage and age at CKD stage in years; 
ESRD, endstage renal disease and age at ESRD in years; KTx, kidney transplantation; ND, no data available; 
CHE, Switzerland; GER, Germany; NDL, Netherlands; TUR, Turkey; neg, negative; pos, positive; y, years.
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technology and an abstract of Morniere et al. who reported the presence of a new five base pair deletion within 
the VNTR identified by the probe extension assay in one of 15 families tested positive. It would be interesting to 
see SMRT-sequencing results of the latter family28,29.
In the largest study on ADTKD-MUC1 24 families, with the insC identified by the snapshot method, have 
been described with high intra- and interfamilial variability regarding the progression of renal disease and onset 
of ESRD20. They speculated on the existence of anticipation (worsening of the phenotype in succeeding genera-
tions) in some families, a phenomenon that has been noted in the very first publication on the MUC1 locus on 
chromosome 1q2125. Although the underlying molecular mechanism in a non-expansion TR would be unclear 
at the moment, precise structural information on the MUC1-VNTR (allele sizes, position of the frameshift muta-
tion, polymorphisms that could possibly alter the structure and thereby the toxicity of the frameshift protein) 
could provide valuable information to predict a potential role of the hypervariable VNTR in anticipation/dis-
ease progression from observer bias. To our knowledge this study contains the most comprehensive data on 
MUC1-VNTR topology, but was neither designed to nor is powered to answer those questions. Assessing the 
impact of coding and noncoding variation for potential genotype phenotype correlations in ADTKD-MUC1 will 
Figure 5. Novel repeat variants. SMRT sequencing revealed nine novel repeat (noncausative) variants. Initially 
detected at the protein level, variant sequences were later defined with respect to their topology in peripheral 
regions of the VNTR domain30–32. According to these studies, the flanking regions were characterized by a 
highly conserved pattern of variant units A-F in genomic DNA from individuals of different ethnic background. 
It was concluded that the variant repeat topology could have resulted from multiple duplication events in the 
phylogeny of the MUC1 repeat domain. Later it was shown that the entire domain contains clusters of variant 
A and B units interspersed in clusters of X units30. As the A, C, E, and F unit exhibit replacements of the 
second proline residue in the STAPPA motif, the expressed mucin is characterized by a pronounced under-
glycosylation here. Again at the protein level the DT to ES replacement within the immunodominant DTR 
motif results in higher conformational flexibility at this site and altered B lymphocyte responses32. Upper case 
letters were continued following the one letter code introduced by Kirby et al. Nucleotide sequence differences 
to the canonical repeat variant “X“ are highlighted in dark grey. The repeat type 5C is a fusion of repeat types 
5 and C. It is composed of the first half of the uniform repeat type 5 and the second half of the repeat type C. 
At the top corresponding amino acid sequences are shown for the canonical and variant-containing units. 
Synonymous variants are marked in light blue. Nonsynonymous variants and corresponding amino acid 
exchanges are highlighted in different colors. Among other variants we identified two novel non-synonymous 
variants in repeat units N and Q resulting in amino acid replacements G to S in the HGT motif (CCG to ACG in 
unit Q) and P to T in the PAP motif (CCG to ACG in unit N).
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require a larger number of resolved VNTR datasets. Thus, our study provides a methodological basis to sequence 
this region which might help to uncover the factors explaining the considerable intra- and interfamilial variability 
in progression of MUC1 related kidney disease.
As the pathomechanisms in ADTKD-MUC1 are likely linked to inflammatory and immune processes in the 
kidney tissue and structural variation in the VNTR domain has been shown to alter B lymphocyte response, 
it is not beyond reason to assume a potential role of the VNTR’s topology here (please see Fig. 5 for further 
information)30–32.
In summary we recommend to perform first line or complementary SMRT sequencing in all snapshot posi-
tive and negative suspected ADTKD-MUC1 cases (to potentially identify novel mutations occurring within the 
VNTR in the latter). We propose to document next to the precise position of the causative mutation, allele lengths 
and (sequence) topology of both the wild type and the disease causing allele in all future studies until the role of 
the VNTR becomes clearer.
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